Key result
First-line treatment with NSAIDs and colchicine provides a good initial response for most patients with acute pericarditis, leading to symptom resolution within a few days.
This review summarizes the clinical findings, diagnosis, and therapeutic management of acute pericarditis, highlighting NSAIDs and colchicine as first-line treatments.
Answers are grounded in this paper and cite their sources.
Supports initial NSAID-colchicine use for acute pericarditis symptom control; leaves open need for prospective trials on dosing and outcomes.
Acute pericarditis is a common disease caused by inflammation of the pericardium, usually benign and self-limited and can occur as an isolated or as a manifestation of a systemic disease entity. Represents 5% of all causes of chest pain in the emergency room. The main etiology are viral infections, although it can also be secondary to systemic diseases and infections. The main complication of acute pericarditis is pericardial effusion, triggering a cardiac tamponade. The first line of treatment is the use of anti-inflammatory and or acetylsalicylic acid. Most patients have a good initial response to an NSAID associated to colchicine and became asymptomatic within a few days. This review article seeks to contemplate the main clinical findings and armed investigation to optimize the diagnosis of this important disease, as well as addressing their therapeutic management.
No takes yet. Share an insight, caveat, or question.
Tonini et al. (2015) conducted a review in Acute pericarditis. First-line treatment with NSAIDs and colchicine provides a good initial response for most patients with acute pericarditis, leading to symptom resolution within a few days.
Synapse has enriched 10 related papers. Consider them for comparative context: